Ensign Peak Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Ensign Peak Advisors’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,400	Closed	-$414K	–	1802
2022 Q4	$414K	Buy	30,400 +12,700	+72%	+$177K	﹤0.01%	1660
2022 Q3	$245K	Sell	17,700 -100	-0.6%	-$1.49K	﹤0.01%	1794
2022 Q2	$256K	Hold	17,800	–	–	﹤0.01%	1722
2022 Q1	$402K	Hold	17,800	–	–	﹤0.01%	1648
2021 Q4	$334K	Sell	17,800 -11,000	-38%	-$294K	﹤0.01%	1778
2021 Q3	$946K	Hold	28,800	–	–	﹤0.01%	1454
2021 Q2	$1.23M	Hold	28,800	–	–	﹤0.01%	1360
2021 Q1	$1.1M	Hold	28,800	–	–	﹤0.01%	1392
2020 Q4	$1.26M	Hold	28,800	–	–	﹤0.01%	1300
2020 Q3	$1.13M	Hold	28,800	–	–	﹤0.01%	1257
2020 Q2	$909K	Hold	28,800	–	–	﹤0.01%	1307
2020 Q1	$1.01M	Hold	28,800	–	–	﹤0.01%	1163
2019 Q4	$1.4M	Buy	+28,800	New	+$1.31M	﹤0.01%	1204

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Ensign Peak Advisors's CSII Position: Q1 2023 in Review

Ensign Peak Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 30,400 shares — an estimated $414K sold.

Ensign Peak Advisors first reported a position in CSII in Q4 2019 and held it in 13 quarters. The position peaked at $1.4M in Q4 2019. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Ensign Peak Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Ensign Peak Advisors sold 30,400 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $414K.
Ensign Peak Advisors first reported a position in Cardiovascular Systems, Inc. in Q4 2019 and held it in 13 quarters.
Ensign Peak Advisors's Cardiovascular Systems, Inc. position peaked at $1.4M in Q4 2019.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.